Radical radiotherapy in the management of carcinoma of the prostate.
Reasons for the increased role of radical radiotherapy in the management of carcinoma of the prostate are presented. The results of a retrospective survey of 116 patients who received radical external beam radiotherapy to the primary tumour are reviewed. Local tumour control was obtained in 75% of patients with an overall morbidity of 14% mild and 9% severe side effects. The problems of accurate tumour staging, extended field radiotherapy and patient selection are discussed. In selected cases, treatment morbidity may be reduced by using interstitial implant techniques.